How HIV PrEP works
PrEP uses antiretroviral medicine before exposure so HIV has far less chance to establish infection.

DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
HOW IT WORKS
From consultation to collection
- 1
Step 1
Consultation
Answer a secure medical questionnaire online.
- 2
Step 2
Doctor reviews
An EU-licensed doctor personally assesses your case.
- 3
Step 3
Prescription in less than 4 hours on average
If approved, your prescription is issued in less than 4 hours on average.
- 4
Step 4
Collect at any EU pharmacy
Use an approved prescription at a pharmacy anywhere in the EU.
Pre-exposure prophylaxis, or PrEP, is medicine taken by an HIV-negative person to reduce the chance of acquiring HIV. It is one part of combination prevention alongside testing, condoms where wanted, STI care and prompt access to PEP after an emergency exposure.
Blocking early HIV replication
Established oral PrEP combines antiretroviral medicines that block reverse transcriptase, an enzyme HIV needs to copy its genetic material after entering a cell. When enough medicine is present at exposed tissues, the virus is much less able to establish a lasting infection. PrEP does not remove HIV from a person who already has it and is not a complete HIV-treatment regimen.
Adherence creates the protection
Protection depends on following the agreed schedule. Tablets need time and consistent dosing to reach protective levels, and protection does not disappear or appear at the same speed in every tissue. A clinician should explain when you can rely on PrEP and how long to continue after the last possible exposure.
What PrEP does not prevent
PrEP does not prevent gonorrhoea, chlamydia, syphilis, pregnancy or every route of viral hepatitis. Regular STI screening and vaccinations where appropriate remain useful. Condoms are still an option for broader protection, but PrEP can add a strong HIV-specific layer when taken correctly.
When to seek help
PrEP must not be started or restarted without excluding HIV infection at the appropriate time. Fever, rash, sore throat, swollen glands or a flu-like illness after a recent exposure may be signs of acute HIV and need prompt testing. A very recent high-risk exposure may call for urgent post-exposure prophylaxis instead; PEP is time-sensitive and should be assessed immediately.
What to prepare for a medical review
A PrEP review covers recent exposures, the timing and type of HIV tests, kidney function, hepatitis B status, other medicines, pregnancy where relevant, and a wider STI screen. Follow-up testing is essential even when you feel well. Protection depends on taking the agreed schedule correctly, and national access pathways can differ across Europe.
A calm next step
Start with an appropriate HIV test and a clinician-led plan, not tablets from another person. The first prescription should include clear start, missed-dose, follow-up and stopping instructions.
Clinical sources used: European Centre for Disease Prevention and Control PrEP standards and European Medicines Agency product information for emtricitabine/tenofovir disoproxil.